Not available
Quote | Neovasc Inc. (NASDAQ:NVCN)
Last: | $30.03 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $30.03 |
High: | $0 |
Low: | $0 |
Volume: | 2 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Neovasc Inc. (NASDAQ:NVCN)
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
2023-04-03 00:36:41 ET Neovasc press release ( NASDAQ: NVCN ): FY GAAP EPS of -$15.07. Revenue of $3.81M (+49.4% Y/Y). For further details see: Neovasc GAAP EPS of -$15.07, revenue of $3.81M
Message Board Posts | Neovasc Inc. (NASDAQ:NVCN)
Subject | By | Source | When |
---|---|---|---|
Can someone feel in this gap? Since $NVCN | Crapola2theleft | investorshub | 03/08/2023 5:28:34 PM |
FREE $NVCN REPORT | Crapola2theleft | investorshub | 01/17/2023 3:10:23 PM |
whytestocks: $NVCN News Article - Shockwave Medical to Acquire Neovasc | whytestocks | investorshangout | 01/17/2023 3:00:45 PM |
whytestocks: $NVCN News Article - Shockwave Medical Announces Agreement to Acquire Neovasc | whytestocks | investorshangout | 01/17/2023 2:55:48 PM |
Very low volume but glad to see it | zeusgodmd | investorshub | 12/27/2022 7:12:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...